PB Ratio: 7.96

Basis: FMP quote market capitalization / matching reported stockholders equity. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 7.96 is 202% above its estimated 5-year average of 2.63, near the low end of its estimated 5-year range (0.87–29.31).

As of 2026-09-09T20:00:01.000Z. 282.50% above its estimated 12-month average of 2.08.

MRNA PB Ratio Metrics

P/B vs. estimated history

At 7.96, P/B is above its estimated 8-year median — higher than 76% of readings in its estimated 8-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Moderna, Inc. (MRNA)?

The P/B ratio for MRNA stock is 7.96.

Is Moderna, Inc.'s P/B ratio high or low?

The P/B ratio of 7.96 is 202% above its estimated 5-year average of 2.63, near the low end of its estimated 5-year range (0.87–29.31).

What is the estimated TTM average P/B ratio for Moderna, Inc. (MRNA)?

The estimated TTM average P/B ratio for MRNA stock is 2.08.

What is the estimated 3Y average P/B ratio for Moderna, Inc. (MRNA)?

The estimated 3Y average P/B ratio for MRNA stock is 2.10.

What is the estimated 5Y average P/B ratio for Moderna, Inc. (MRNA)?

The estimated 5Y average P/B ratio for MRNA stock is 2.63.

Showing the most recent 260 of 1,948 data points. The chart above shows the full history.

Related Metrics